Coronavirus Update: SK Bioscience, Biological E, DongWha And Celltrion Report Progress

 
• By Scrip Team

SK set for Korean trial with vaccine, as Biological E begins human trials of Baylor vaccine. Meanwhile, DongWha gets a Phase II nod for potential drug, and Celltrion progesses with Phase II regdanvimab trial.  

Coronavirus map
• Source: Shutterstock

More from Clinical Trials

More from R&D